跳至主要内容
临床试验/IRCT201201154536N2
IRCT201201154536N2已完成1 期

Study for safety and efficacy of intramuscular Administration of MASPORT® manufactured by Masoondarou Co. (phase 1 and 2)

Masoondarou Co.0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • male or females age between 18 to 60 years old with moderate to severe glabellar facial lines
  • Exclusion criteria: evidence of any unusual condition in volunteer, i.e.: severe allergic reactions, need for use of corticosteroids, evidence of pregnancy before administration of products and abnormal results of paraclinical tests (leukocytopenia , leukocytosis , thrombocytopenia , anemia , hyperkalemia , hypokalemia , hypernatremia , hyponatremia) .

排除标准

  • 未提供

研究者

发起方
Masoondarou Co.

相似试验